(MENAFN– Investor Brand Network) Researchers from the Imperial College London’s Center for Psychedelic Research have
announced plans
to carry out a clinical trial exploring the potential of psychedelics as gambling addiction treatments. After recently studying psychedelics-assisted therapies in treating depression, the center is now looking to investigate whether psilocybin has
therapeutic potential against addictions
such as gambling.
It will be the first study exploring psychedelics as treatments for addiction and is slated to begin in October 2023 with five participants and a…
read more>>
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates
psychedelicnewsbreaks
designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text“Groovy” to 844-397-5787 (U.S. Mobile Phones Only)
For more information please visit
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published:
Do you have questions or are you interested in working with PNW?
ask our editor
PsychedelicNewsWire (PNW)
San Francisco, California
415.949.5050 Office
PsychedelicNewsWire is part of the
investorbrandnetwork .
